Leiner Disease: Causes, Symptoms, Diagnosis, Treatment

Author: Dermatology Staff Writer, Updated 2026

Leiner disease is a rare and severe condition that primarily affects infants, characterised by generalised

erythroderma

resembling severe seborrhoeic dermatitis, alongside recurrent diarrhoea, frequent skin and systemic infections, and significant

failure to thrive

. Also known as erythroderma desquamativum, this disorder typically emerges within the first few months of life and poses substantial risks due to immune dysfunction.

What is Leiner disease?

Leiner disease represents a distinctive syndrome in early infancy, marked by a clinical tetrad: widespread exfoliative dermatitis, persistent gastrointestinal disturbances like malabsorptive diarrhoea, superimposed bacterial or fungal infections, and profound wasting or failure to thrive. Infants exhibit bright red, scaly skin covering much of the body, leading to complications such as thermoregulatory impairment, severe fluid loss from exfoliation, fever, anaemia, and weight loss.

Historically described by Max Leiner in 1908, the condition was more frequently reported in Europe during eras of higher infectious disease prevalence, but remains rare today, affecting fewer than 200,000 individuals in the United States. It is listed among rare diseases with hallmark features including immune system abnormalities (90% frequency) and failure to thrive (90-99% frequency).

Who gets Leiner disease?

Leiner disease predominantly manifests in

infants under 6 months of age

, often within the first 2-3 months of life, though it may be present at birth in some cases. It appears more common in

female infants

and those who are

breast-fed

, though the reasons for these associations remain unclear.

Affecting newborns and young infants globally, it is classified under rare skin diseases and immune deficiencies. No strong ethnic predispositions are noted, but its rarity means most cases are sporadic. Familial forms have been linked to genetic complement deficiencies, suggesting a hereditary component in select patients.

• Age: Neonatal to 6 months, peak in first 2 months
• Sex: Female predominance
• Feeding: More common in breast-fed infants
• Rarity: <200,000 cases in US population

Causes

The precise aetiology of Leiner disease remains elusive, but a central role is played by

defects in the complement system

, a critical component of innate immunity. Specifically,

deficient opsonic activity

—the process by which pathogens are coated for phagocytosis—has been consistently demonstrated. Inherited dysfunction or deficiency in the

C5 component of complement

(or sometimes C3) impairs opsonisation of yeasts like Candida and bacteria such as Staphylococcus aureus, predisposing infants to recurrent infections.

This immune defect, combined with severe dermatitis, creates a vicious cycle: damaged skin barrier facilitates microbial invasion, while poor opsonisation hinders clearance. Other contributing factors may include nutritional deficits, though biotin deficiency is more a treatment target than a primary cause. Unlike typical seborrhoeic dermatitis linked to Malassezia overgrowth, Leiner disease stems from systemic immune compromise rather than local fungal proliferation.

Familial cases underscore genetic underpinnings, with complement assays revealing low CH50 levels (total haemolytic complement). Acquired factors, such as maternal antibody interference or transient immaturity of the infant immune system, have been hypothesised but lack confirmation.

Clinical features

The eruption typically begins as a scaly rash in seborrhoeic areas—**scalp**,

face

, or

napkin (diaper) area

—before rapidly generalising to

erythroderma

covering trunk, limbs, and flexures. Affected skin is brightly erythematous, oedematous, and covered in thick, greasy yellow-white scales that desquamate profusely.

Infants appear ill and uncomfortable but rarely exhibit pruritus (itching). Key associated features include:

• Recurrent diarrhoea: Profuse, malabsorptive, leading to dehydration and malnutrition
• Failure to thrive: Poor weight gain, wasting, anaemia, fever
• Infections: Local (impetigo, candidiasis) or systemic (pneumonia, meningitis, sepsis)
• Thermoregulatory issues: Heat loss from exfoliation, risking hypothermia
• Fluid/electrolyte imbalance: High insensible losses from denuded skin

Systemic signs like tachycardia, tachypnoea, and lethargy signal severity. In darker skin types, erythema may appear violaceous with hypopigmented scaling, akin to severe seborrhoeic dermatitis variants. A case example involved a 1-month-18-day-old boy with 10 days of white scaly skin and fever, progressing to erythroderma.

Diagnosis

Diagnosis is primarily

clinical

, based on the characteristic tetrad in an infant with erythroderma. Key investigations confirm immune dysfunction:

Test	Purpose	Expected Finding
Complement assays (C3, C5, CH50)	Assess opsonic activity	Low C5 or total complement
Culture/swabs	Identify superinfections	S. aureus, Candida, Gram-negatives
Full blood count	Detect anaemia, infection	Leucocytosis or eosinophilia
Stool studies	Evaluate diarrhoea	Malabsorption, pathogens

Histology shows non-specific psoriasiform dermatitis with parakeratosis and spongiosis. Complement studies are pivotal to distinguish from other immunodeficiencies.

Differential diagnosis

Leiner disease must be differentiated from other causes of infantile erythroderma:

• Omenn syndrome: T-cell immunodeficiency with eosinophilia, alopecia
• Severe seborrhoeic dermatitis/cradle cap: Lacks systemic features
• Atopic dermatitis: Itchy, flexural, no complement defect
• Immunodeficiencies (SCID, Wiskott-Aldrich): More profound infections
• Metabolic disorders
• Psoriasis or ichthyosis: Different scaling patterns

Failure to identify the complement defect risks misdiagnosis as refractory eczema.

Treatment

Management requires

hospitalisation

for fluid resuscitation, nutritional support, and infection control. Emollients (bland, like white soft paraffin) soothe skin and reduce losses.

Fresh frozen plasma

(FFP) replenishes complement, improving opsonisation.

• Skin care: Frequent emollient baths, wet wraps
• Nutrition: Enteral/parenteral feeding to combat malabsorption
• Antibiotics/antifungals: Targeted to cultures (e.g., fluconazole for Candida)
• Biotin supplementation: 5-10 mg/day; empirical benefit in some cases
• Immunomodulators: FFP infusions (10-20 mL/kg every 2-3 days)

Supportive care addresses thermoregulation (incubators) and monitoring for sepsis. With aggressive therapy, infants often recover fully post-infancy.

Outcome

Prognosis is guarded without prompt intervention, with risks of mortality from sepsis or dehydration. However, most treated infants survive and lead normal lives beyond infancy, as the complement defect may be transient. Recurrence is rare post-resolution. Long-term follow-up assesses growth and immunity.

Frequently asked questions

Q: Is Leiner disease contagious?

A: No, it is not infectious; secondary bacterial/fungal overgrowth occurs due to immune and skin barrier defects.

Q: Can Leiner disease be cured?

A: It often resolves with supportive treatment in infancy, though some require ongoing immune monitoring.

Q: What is the role of biotin in treatment?

A: Biotin supplementation aids skin healing and may correct associated deficiencies, though not curative of the complement defect.

Q: How is Leiner disease different from cradle cap?

A: Cradle cap is localised seborrhoeic dermatitis without systemic illness or immune deficiency; Leiner generalises with severe complications.

Q: Is Leiner disease hereditary?

A: Familial cases link to complement gene mutations (e.g., C5), but most are sporadic.